MedTrace Logo

DILIPO (DILutIonal HyPOnatremia)

NCT00274326 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2008-09-15

No results posted yet for this study

Summary

Primary:

* To assess the efficacy of SR121463B in correcting hyponatremia in patients with dilutional hyponatremia other than SIADH or cirrhosis

Secondary:

* To assess the long-term efficacy of SR121463B in maintaining normonatremia in these patients
* To assess the safety and tolerability of SR121463B

Conditions

  • Congestive Heart Failure

Interventions

DRUG

SR121463B

Sponsors & Collaborators

Principal Investigators

  • Daniel Ter-Minassian, MD · Sanofi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2007-07-31
Completion
2007-07-31

Countries

  • United States
  • Argentina
  • Australia
  • Belgium
  • Canada
  • Chile
  • Denmark
  • Greece
  • Hungary
  • Israel
  • Poland
  • Portugal
  • Romania
  • South Africa
  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00274326 on ClinicalTrials.gov